| SC 13G/A | 2022-02-11 | Novartis Bioventures Ltd | Annexon, Inc. | 910,747 | 2.4% | EDGAR |
| SC 13G | 2022-02-10 | PICTET ASSET MANAGEMENT SA | Annexon, Inc. | 21 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Annexon, Inc. | 1,340,027 | 3.5% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Annexon, Inc. | 2,614,591 | 6.8% | EDGAR |
| SC 13G/A | 2021-11-19 | New Enterprise Associates 15, L.P. | Annexon, Inc. | - | - | EDGAR |
| SC 13D/A | 2021-08-27 | Blackstone Holdings II L.P. | Annexon, Inc. | 1,820,423 | 4.7% | EDGAR |
| SC 13G/A | 2021-02-16 | CITADEL ADVISORS LLC | Annexon, Inc. | - | 5.5% | EDGAR |
| SC 13G/A | 2021-02-16 | Zone II Healthcare Holdings, LLC | Annexon, Inc. | 1,356,415 | 3.6% | EDGAR |
| SC 13G | 2021-02-16 | Redmile Group, LLC | Annexon, Inc. | 3,448,030 | 9.0% | EDGAR |
| SC 13G | 2021-02-16 | Bain Capital Life Sciences Fund, L.P. | Annexon, Inc. | 2,940,627 | 7.7% | EDGAR |
| SC 13G | 2021-02-12 | New Enterprise Associates 15, L.P. | Annexon, Inc. | 2,495,687 | 6.5% | EDGAR |
| SC 13G | 2021-02-12 | Satter Muneer A | Annexon, Inc. | 1,954,978 | 5.1% | EDGAR |
| SC 13G | 2021-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | Annexon, Inc. | 2,004,616 | 5.3% | EDGAR |
| SC 13G | 2021-02-08 | FMR LLC | Annexon, Inc. | 2,200,886 | 5.8% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Annexon, Inc. | 2,487,333 | 6.5% | EDGAR |
| SC 13G | 2021-01-29 | Novartis Bioventures Ltd | Annexon, Inc. | 2,107,244 | 5.5% | EDGAR |
| SC 13D | 2020-08-07 | Blackstone Holdings II L.P. | Annexon, Inc. | 2,730,635 | 7.6% | EDGAR |
| SC 13G | 2020-08-07 | CITADEL ADVISORS LLC | Annexon, Inc. | - | 5.5% | EDGAR |
| SC 13G | 2020-08-07 | Zone II Healthcare Holdings, LLC | Annexon, Inc. | 1,485,865 | 4.1% | EDGAR |
| SC 13G | 2020-07-28 | Flynn James E | Annexon, Inc. | 808,914 | 2.2% | EDGAR |